NM_000540.3:c.11908-14A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000540.3(RYR1):​c.11908-14A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.023 in 1,611,892 control chromosomes in the GnomAD database, including 828 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 89 hom., cov: 32)
Exomes 𝑓: 0.023 ( 739 hom. )

Consequence

RYR1
NM_000540.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13O:1

Conservation

PhyloP100: -0.144

Publications

5 publications found
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
RYR1 Gene-Disease associations (from GenCC):
  • malignant hyperthermia, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, ClinGen
  • RYR1-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia
  • congenital multicore myopathy with external ophthalmoplegia
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • central core myopathy
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • King-Denborough syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant hyperthermia of anesthesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • benign Samaritan congenital myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital myopathy with myasthenic-like onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 19-38543757-A-G is Benign according to our data. Variant chr19-38543757-A-G is described in ClinVar as Benign. ClinVar VariationId is 133022.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0687 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000540.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR1
NM_000540.3
MANE Select
c.11908-14A>G
intron
N/ANP_000531.2P21817-1
RYR1
NM_001042723.2
c.11893-14A>G
intron
N/ANP_001036188.1P21817-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR1
ENST00000359596.8
TSL:5 MANE Select
c.11908-14A>G
intron
N/AENSP00000352608.2P21817-1
RYR1
ENST00000355481.8
TSL:1
c.11893-14A>G
intron
N/AENSP00000347667.3P21817-2
RYR1
ENST00000594335.6
TSL:1
n.*2618-14A>G
intron
N/AENSP00000470927.2M0R014

Frequencies

GnomAD3 genomes
AF:
0.0228
AC:
3458
AN:
151828
Hom.:
88
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00789
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0720
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.0610
Gnomad SAS
AF:
0.0333
Gnomad FIN
AF:
0.0444
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0152
Gnomad OTH
AF:
0.0240
GnomAD2 exomes
AF:
0.0347
AC:
8650
AN:
249418
AF XY:
0.0319
show subpopulations
Gnomad AFR exome
AF:
0.00736
Gnomad AMR exome
AF:
0.109
Gnomad ASJ exome
AF:
0.00209
Gnomad EAS exome
AF:
0.0474
Gnomad FIN exome
AF:
0.0447
Gnomad NFE exome
AF:
0.0164
Gnomad OTH exome
AF:
0.0288
GnomAD4 exome
AF:
0.0230
AC:
33543
AN:
1459946
Hom.:
739
Cov.:
36
AF XY:
0.0227
AC XY:
16506
AN XY:
726386
show subpopulations
African (AFR)
AF:
0.00636
AC:
213
AN:
33474
American (AMR)
AF:
0.109
AC:
4859
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.00226
AC:
59
AN:
26134
East Asian (EAS)
AF:
0.0681
AC:
2705
AN:
39700
South Asian (SAS)
AF:
0.0293
AC:
2531
AN:
86254
European-Finnish (FIN)
AF:
0.0441
AC:
2276
AN:
51616
Middle Eastern (MID)
AF:
0.00919
AC:
53
AN:
5766
European-Non Finnish (NFE)
AF:
0.0173
AC:
19256
AN:
1111950
Other (OTH)
AF:
0.0264
AC:
1591
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1946
3892
5837
7783
9729
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
864
1728
2592
3456
4320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0228
AC:
3461
AN:
151946
Hom.:
89
Cov.:
32
AF XY:
0.0255
AC XY:
1893
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.00784
AC:
325
AN:
41458
American (AMR)
AF:
0.0723
AC:
1103
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3460
East Asian (EAS)
AF:
0.0609
AC:
314
AN:
5156
South Asian (SAS)
AF:
0.0334
AC:
160
AN:
4794
European-Finnish (FIN)
AF:
0.0444
AC:
470
AN:
10586
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0152
AC:
1032
AN:
67922
Other (OTH)
AF:
0.0237
AC:
50
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
176
353
529
706
882
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0224
Hom.:
36
Bravo
AF:
0.0240
Asia WGS
AF:
0.0590
AC:
205
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
2
Malignant hyperthermia, susceptibility to, 1 (2)
-
-
2
not provided (3)
-
-
1
Central core myopathy (1)
-
-
1
Congenital multicore myopathy with external ophthalmoplegia (1)
-
-
1
Neuromuscular disease, congenital, with uniform type 1 fiber (1)
-
-
1
RYR1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.97
DANN
Benign
0.54
PhyloP100
-0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2292799; hg19: chr19-39034397; API